{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:01:16Z","timestamp":1792677676631,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Macao Polytechnic University","award":["RP\/FCSD-02\/2025"],"award-info":[{"award-number":["RP\/FCSD-02\/2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02820-2","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T11:18:39Z","timestamp":1766229519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk prediction of multiple cardiometabolic diseases in middle-aged and older adults using lipid metabolism biomarkers and derived composite measures based on machine learning: a prospective cohort study of CHARLS"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"1","key":"2820_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E. Association of cardiometabolic Multimorbidity with mortality in 1 million people. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"10","key":"2820_CR2","first-page":"715","volume":"5","author":"M Kivim\u00e4ki","year":"2017","unstructured":"Kivim\u00e4ki M. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data. Lancet Diabetes Endocrinol. 2017;5(10):715\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2820_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12916-021-02126-x","volume":"19","author":"D Canoy","year":"2021","unstructured":"Canoy D. Cardiometabolic disease multimorbidity and mortality: a population-based cohort study. BMC Med. 2021;19(1):258\u2013258.","journal-title":"BMC Med"},{"issue":"7","key":"2820_CR4","first-page":"e632","volume":"8","author":"RK Owen","year":"2023","unstructured":"Owen RK. Effect on life expectancy of temporal sequence in a cardiometabolic multimorbidity pathway. Lancet Public Health. 2023;8(7):e632-41.","journal-title":"Lancet Public Health"},{"key":"2820_CR5","doi-asserted-by":"publisher","first-page":"830319","DOI":"10.3389\/fcvm.2022.830319","volume":"9","author":"X Cheng","year":"2022","unstructured":"Cheng X. Healthy lifestyle and life expectancy among individuals with cardiometabolic Multimorbidity. Front Cardiovasc Med. 2022;9:830319\u2013830319.","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"2820_CR6","first-page":"230","volume":"135","author":"J Fan","year":"2022","unstructured":"Fan J. Multimorbidity patterns and association with mortality in Chinese adults. Chin Med J. 2022;135(20):230\u20139.","journal-title":"Chin Med J"},{"key":"2820_CR7","first-page":"1","volume":"188","author":"Y Hu","year":"2024","unstructured":"Hu Y. Prevalence and patterns of multimorbidity in china: a systematic review. Maturitas. 2024;188:1\u20139.","journal-title":"Maturitas"},{"key":"2820_CR8","first-page":"1048348","volume":"10","author":"Y Zhao","year":"2023","unstructured":"Zhao Y. Cardiometabolic Multimorbidity among Chinese women: prevalence and associated factors. Front Cardiovasc Med. 2023;10:1048348\u20131048348.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"2820_CR9","first-page":"1040","volume":"29","author":"D Zhang","year":"2019","unstructured":"Zhang D. Trends of cardiometabolic multimorbidity and mortality in 1,038,704 Chinese adults. Nutr Metab Cardiovasc Dis. 2019;29(9):1040\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"34","key":"2820_CR10","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/eurheartj\/ehab413","volume":"42","author":"Y Han","year":"2021","unstructured":"Han Y. Lifestyle, cardiometabolic disease, and Multimorbidity in 0.5 million Chinese adults. Eur Heart J. 2021;42(34):3374\u201384.","journal-title":"Eur Heart J"},{"issue":"1","key":"2820_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12916-023-02745-6","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng Y. Composite healthy lifestyle and risk of cardiometabolic multimorbidity: a prospective study. BMC Med. 2023;21(1):46\u201346.","journal-title":"BMC Med"},{"issue":"2","key":"2820_CR12","first-page":"e95","volume":"7","author":"J Gong","year":"2022","unstructured":"Gong J. Multimorbidity and out-of-pocket expenditures among middle-aged and older adults in china: evidence from CHARLS. Lancet Public Health. 2022;7(2):e95\u2013104.","journal-title":"Lancet Public Health"},{"issue":"4","key":"2820_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","volume":"53","author":"JG Robinson","year":"2009","unstructured":"Robinson JG. Non\u2013HDL cholesterol and coronary heart disease risk prediction. J Am Coll Cardiol. 2009;53(4):316\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2820_CR14","first-page":"263","volume":"60","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM. Non-HDL cholesterol vs LDL cholesterol for risk prediction: meta-analysis. J Am Coll Cardiol. 2012;60(3):263\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2820_CR15","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"S Parish","year":"2009","unstructured":"Parish S. Blood lipids and vascular disease: emerging risk factors collaboration. JAMA. 2009;302(18):1993\u20132000.","journal-title":"JAMA"},{"issue":"4","key":"2820_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE. The triglyceride\u2013glucose index as a surrogate marker of insulin resistance. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2820_CR17","first-page":"32","volume":"55","author":"ACJ Vasques","year":"2011","unstructured":"Vasques ACJ. TyG index and HOMA-IR performance comparison. Arch Endocrinol Metab. 2011;55(1):32\u20138.","journal-title":"Arch Endocrinol Metab"},{"issue":"17","key":"2820_CR18","first-page":"e3647","volume":"95","author":"LK Er","year":"2016","unstructured":"Er LK. Triglyceride glucose\u2013body mass index (TyG\u2013BMI) and incident diabetes. Med (Baltim). 2016;95(17):e3647\u20133647.","journal-title":"Med (Baltim)"},{"key":"2820_CR19","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41598-017-03656-2","volume":"7","author":"L S\u00e1nchez-\u00cd\u00f1igo","year":"2017","unstructured":"S\u00e1nchez-\u00cd\u00f1igo L. TyG-related indices and cardiovascular risk in a prospective cohort. Sci Rep. 2017;7:3423\u20133423.","journal-title":"Sci Rep"},{"issue":"1","key":"2820_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2337\/diacare.29.01.06.dc05-1805","volume":"29","author":"HS Kahn","year":"2006","unstructured":"Kahn HS. The lipid accumulation product as a measure of visceral adiposity. Diabetes Care. 2006;29(1):151\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"2820_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC. Visceral adiposity index: a reliable indicator of visceral fat function. Diabetes Care. 2010;33(4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"1","key":"2820_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3803\/EnM.2016.31.1.64","volume":"31","author":"N Motamed","year":"2016","unstructured":"Motamed N. Lipid accumulation product and metabolic syndrome. Endocrinol Metab. 2016;31(1):64\u201374.","journal-title":"Endocrinol Metab"},{"issue":"10","key":"2820_CR23","first-page":"1007","volume":"28","author":"H Dai","year":"2018","unstructured":"Dai H. Atherogenic index of plasma and cardiovascular risk. Nutr Metab Cardiovasc Dis. 2018;28(10):1007\u201314.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"2820_CR24","first-page":"700","volume":"16","author":"S Li","year":"2022","unstructured":"Li S. Triglyceride-glucose index and incident diabetes: a meta-analysis. Prim Care Diabetes. 2022;16(5):700\u201310.","journal-title":"Prim Care Diabetes"},{"key":"2820_CR25","first-page":"903372","volume":"9","author":"M Zhang","year":"2022","unstructured":"Zhang M. Triglyceride-glucose index and cardiovascular disease risk: systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:903372\u2013903372.","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"2820_CR26","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/nu14163254","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen Y. Lipid accumulation product (LAP) and cardiovascular risk: a systematic review. Nutrients. 2022;14(16):3254\u20133254.","journal-title":"Nutrients"},{"issue":"6","key":"2820_CR27","first-page":"1230","volume":"32","author":"J Fu","year":"2022","unstructured":"Fu J. Visceral adiposity index and cardiometabolic outcomes: a systematic review. Nutr Metab Cardiovasc Dis. 2022;32(6):1230\u201340.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2820_CR28","first-page":"129","volume":"60","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG. Triglycerides and remnant cholesterol: causal or not? Clin Chem. 2014;60(1):129\u201331.","journal-title":"Clin Chem"},{"key":"2820_CR29","doi-asserted-by":"publisher","first-page":"1518840","DOI":"10.3389\/fnut.2025.1518840","volume":"12","author":"C Zhou","year":"2025","unstructured":"Zhou C. METS-IR and cardiometabolic Multimorbidity in Chinese adults: a nationwide longitudinal study. Front Nutr. 2025;12:1518840\u20131518840.","journal-title":"Front Nutr"},{"issue":"Supplement1","key":"2820_CR30","first-page":"ehae666","volume":"45","author":"C Janssen-Telders","year":"2024","unstructured":"Janssen-Telders C, Schlaich M, Schutte A, Stergiou G, Poulter N, Beaney T. Risk factors for cardiometabolic multimorbidity: an analysis of 4 million participants from May measurement month 2017\u20132019. Eur Heart J. 2024;45(Supplement1):ehae666.","journal-title":"Eur Heart J"},{"key":"2820_CR31","doi-asserted-by":"publisher","first-page":"1302296","DOI":"10.3389\/fendo.2024.1302296","volume":"15","author":"T Dong","year":"2024","unstructured":"Dong T, Lin W, Zhou Q, Yang Y, Liu X, Chen J, et al. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study. Front Endocrinol. 2024;15:1302296.","journal-title":"Front Endocrinol"},{"key":"2820_CR32","first-page":"c4671","volume":"341","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW. Clinical prediction models: A practical approach to development, validation, and updating (evaluation concepts). BMJ. 2010;341:c4671\u20134671.","journal-title":"BMJ"},{"issue":"1","key":"2820_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva A. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24\u20139.","journal-title":"Nat Med"},{"key":"2820_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41746-018-0029-1","volume":"1","author":"A Rajkomar","year":"2018","unstructured":"Rajkomar A. Scalable and accurate deep learning with electronic health records. NPJ Digit Med. 2018;1:18\u201318.","journal-title":"NPJ Digit Med"},{"issue":"4","key":"2820_CR35","doi-asserted-by":"publisher","first-page":"e0174944","DOI":"10.1371\/journal.pone.0174944","volume":"12","author":"SF Weng","year":"2017","unstructured":"Weng SF. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One. 2017;12(4):e0174944-0174944.","journal-title":"PLoS One"},{"issue":"1","key":"2820_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2820_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10641963.2018.1445751","volume":"41","author":"Z Li","year":"2019","unstructured":"Li Z, Fu C, Yang F, et al. Prevalence and risk factors of hypertension for the middle-aged population in China\u2014results from the China Health and Retirement Longitudinal Study (CHARLS)[J]. Clin Exp Hypertens. 2019;41(1):80\u20136.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"2820_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS)[J]. Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"key":"2820_CR39","unstructured":"Lundberg S M, Lee S I. A unified approach to interpreting model predictions[J]. Advances in neural information processing systems, 2017, 30.Lundberg SM. A Unified Approach to Interpreting Model Predictions. In: Advances in Neural Information Processing Systems (NeurIPS): 2017;2017."},{"key":"2820_CR40","unstructured":"Lundberg SM. Consistent individualized feature attribution for tree ensembles. In: Advances in Neural Information Processing Systems (NeurIPS): 2018;2018."},{"issue":"1","key":"2820_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM. From local explanations to global understanding with explainable AI. Nat Mach Intell. 2020;2(1):252\u201364.","journal-title":"Nat Mach Intell"},{"key":"2820_CR42","first-page":"1","volume":"2","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Strauss J, Yang G, Giles J, Hu P, Hu Y, et al. China health and retirement longitudinal study\u20132011\u20132012 national baseline users\u2019 guide. Beijing: Natl School Dev Peking Univ. 2013;2:1\u201356.","journal-title":"Beijing: Natl School Dev Peking Univ"},{"issue":"1","key":"2820_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2820_CR44","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu P, Kim JK, Meng Q, Strauss J, Wang Y, Zeng J, Zhang Y, Zhao Y. Venous blood-based biomarkers in the China health and retirement longitudinal study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188(11):1871\u20137.","journal-title":"Am J Epidemiol"},{"key":"2820_CR45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-023-01826-3","volume":"22","author":"H Lee","year":"2023","unstructured":"Lee H. TyG-BMI and arterial stiffness\/metabolic phenotypes. Cardiovasc Diabetol. 2023;22:96\u201396.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2820_CR46","first-page":"111","volume":"110","author":"J Liu","year":"2006","unstructured":"Liu J. Non\u2013HDL cholesterol and coronary heart disease risk in Chinese populations. Int J Cardiol. 2006;110(1):111\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2820_CR47","first-page":"145","volume":"234","author":"A Varbo","year":"2014","unstructured":"Varbo A. Remnant cholesterol and ischemic heart disease. Atherosclerosis. 2014;234(1):145\u20137.","journal-title":"Atherosclerosis"},{"issue":"24","key":"2820_CR48","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","volume":"34","author":"A Varbo","year":"2013","unstructured":"Varbo A. Remnant cholesterol as a causal risk factor for ischemic heart disease. Eur Heart J. 2013;34(24):1826\u201333.","journal-title":"Eur Heart J"},{"issue":"4","key":"2820_CR49","first-page":"594","volume":"62","author":"A Langsted","year":"2016","unstructured":"Langsted A. Remnant cholesterol and cardiovascular risk: clinical chemistry perspective. Clin Chem. 2016;62(4):594\u2013602.","journal-title":"Clin Chem"},{"issue":"1","key":"2820_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.117.030677","volume":"137","author":"V Sathiyakumar","year":"2018","unstructured":"Sathiyakumar V. Fasting vs nonfasting lipid profiles and remnant cholesterol. Circulation. 2018;137(1):10\u20139.","journal-title":"Circulation"},{"key":"2820_CR51","first-page":"11","volume":"329","author":"HH Liu","year":"2021","unstructured":"Liu HH. Remnant cholesterol and atherosclerotic risk: a meta-analysis. Atherosclerosis. 2021;329:11\u201321.","journal-title":"Atherosclerosis"},{"issue":"2","key":"2820_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0893-6080(05)80023-1","volume":"5","author":"DH Wolpert","year":"1992","unstructured":"Wolpert DH. Stacked generalization. Neural Netw. 1992;5(2):241\u201359.","journal-title":"Neural Netw"},{"issue":"1","key":"2820_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356.","journal-title":"Nat Med"},{"issue":"3","key":"2820_CR54","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER. Comparing the areas under two or more correlated receiver operating characteristic curves. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"key":"2820_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B. Calibration: the achilles\u2019 heel of predictive analytics. BMC Med. 2019;17:230\u2013230.","journal-title":"BMC Med"},{"issue":"10","key":"2820_CR56","first-page":"2239","volume":"31","author":"L Liou","year":"2024","unstructured":"Liou L. Calibration and bias of deployed machine learning models in health care. J Am Med Inform Assoc. 2024;31(10):2239\u201350.","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"2820_CR57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u201374.","journal-title":"Med Decis Making"},{"key":"2820_CR58","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ. Net benefit approaches to evaluating the clinical utility of predictive models. BMJ. 2016;352:i6\u20136.","journal-title":"BMJ"},{"issue":"2","key":"2820_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0272989X14547233","volume":"35","author":"B Van Calster","year":"2015","unstructured":"Van Calster B. Calibration and decision-analytic performance of risk prediction models. Med Decis Making. 2015;35(2):162\u20139.","journal-title":"Med Decis Making"},{"key":"2820_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77\u201377.","journal-title":"BMC Bioinformatics"},{"key":"2820_CR61","doi-asserted-by":"crossref","unstructured":"Susmaga R. Confusion matrix visualization. In: Intelligent Information Processing and Web Mining: Proceedings of the International IIS: IIPWM \u201804 Conference held in Zakopane, Poland, May 17\u201320, 2004: 2004: Springer; 2004: 107\u2013116.","DOI":"10.1007\/978-3-540-39985-8_12"},{"issue":"1","key":"2820_CR62","first-page":"120","volume":"710","author":"S Visa","year":"2011","unstructured":"Visa S, Ramsay B, Ralescu AL, Van Der Knaap E. Confusion matrix-based feature selection. Maics. 2011;710(1):120\u20137.","journal-title":"Maics"},{"issue":"1","key":"2820_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","volume":"78","author":"GW Brier","year":"1950","unstructured":"Brier GW. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78(1):1\u20133.","journal-title":"Mon Weather Rev"},{"key":"2820_CR64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jbi.2014.12.016","volume":"54","author":"K Van Hoorde","year":"2015","unstructured":"Van Hoorde K. A flexible tool for constructing calibration plots. J Biomed Inform. 2015;54:283\u201393.","journal-title":"J Biomed Inform"},{"key":"2820_CR65","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1613\/jair.1.13283","volume":"74","author":"G Van den Broeck","year":"2022","unstructured":"Van den Broeck G, Lykov A, Schleich M, Suciu D. On the tractability of SHAP explanations. J Artif Intell Res. 2022;74:851\u201386.","journal-title":"J Artif Intell Res"},{"key":"2820_CR66","doi-asserted-by":"publisher","first-page":"106584","DOI":"10.1016\/j.cmpb.2021.106584","volume":"214","author":"Y Nohara","year":"2022","unstructured":"Nohara Y, Matsumoto K, Soejima H, Nakashima N. Explanation of machine learning models using Shapley additive explanation and application for real data in hospital. Comput Methods Programs Biomed. 2022;214:106584.","journal-title":"Comput Methods Programs Biomed"},{"key":"2820_CR67","unstructured":"Sundararajan M, Najmi A. The many Shapley values for model explanation. In: International conference on machine learning: 2020: PMLR; 2020: 9269\u20139278."},{"issue":"3","key":"2820_CR68","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1080\/10618600.2021.2007935","volume":"31","author":"A Inglis","year":"2022","unstructured":"Inglis A, Parnell A, Hurley CB. Visualizing variable importance and variable interaction effects in machine learning models. J Comput Graph Stat. 2022;31(3):766\u201378.","journal-title":"J Comput Graph Stat"},{"issue":"1","key":"2820_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/biom.13392","volume":"77","author":"BD Williamson","year":"2021","unstructured":"Williamson BD, Gilbert PB, Carone M, Simon N. Nonparametric variable importance assessment using machine learning techniques. Biometrics. 2021;77(1):9\u201322.","journal-title":"Biometrics"},{"issue":"2","key":"2820_CR70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/13658816.2018.1533136","volume":"33","author":"G L\u00fc","year":"2019","unstructured":"L\u00fc G, Batty M, Strobl J, Lin H, Zhu A-X, Chen M. Reflections and speculations on the progress in geographic information systems (GIS): a geographic perspective. Int J Geogr Inf Sci. 2019;33(2):346\u201367.","journal-title":"Int J Geogr Inf Sci"},{"key":"2820_CR71","doi-asserted-by":"publisher","first-page":"e4483","DOI":"10.1136\/bmj.e4483","volume":"345","author":"P Sedgwick","year":"2012","unstructured":"Sedgwick P Pearson\u2019s correlation coefficient. BMJ. 2012;345:e4483. https:\/\/doi.org\/10.1136\/bmj.e4483.","journal-title":"BMJ"},{"key":"2820_CR72","doi-asserted-by":"crossref","unstructured":"Babaahmadi\u2010Rezaei H, Raeisizadeh M, Zarezade V, et al. Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS)[J]. Diabetol Metabol Syndr. 2024;16(1):112.","DOI":"10.1186\/s13098-024-01349-1"},{"issue":"1","key":"2820_CR73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12902-022-01209-x","volume":"23","author":"X Li","year":"2023","unstructured":"Li X, Zhang H, Wang L, et al. Predicting metabolic syndrome by obesity- and lipid-related indices: a cross-sectional and longitudinal study. BMC Endocr Disorders. 2023;23(1):15.","journal-title":"BMC Endocr Disorders"},{"issue":"2","key":"2820_CR74","first-page":"230","volume":"38","author":"J-H Moon","year":"2023","unstructured":"Moon J-H, et al. Triglyceride-Glucose index predicts future atherosclerotic cardiovascular disease in the general population. Endocrinol Metabolism. 2023;38(2):230\u20139.","journal-title":"Endocrinol Metabolism"},{"key":"2820_CR75","unstructured":"Mirzadeh M, Kizel R, Sakib MN et al. Atherogenic index of plasma as a predictor of coronary artery disease. BMC Cardiovasc Disord. 2024."},{"issue":"1","key":"2820_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gheart.2013.01.001","volume":"8","author":"RB D\u2019Agostino","year":"2013","unstructured":"D\u2019Agostino RB. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013;8(1):11\u201323.","journal-title":"Glob Heart"},{"key":"2820_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22169-6","author":"E Church","year":"2025","unstructured":"Church E, Poppe K, Wells S. Scoping review of the use of multimorbidity variables in cardiovascular disease risk prediction. BMC Public Health. 2025. https:\/\/doi.org\/10.1186\/s12889-025-22169-6.","journal-title":"BMC Public Health"},{"issue":"1","key":"2820_CR78","doi-asserted-by":"publisher","first-page":"8559677","DOI":"10.1155\/jdr\/8559677","volume":"2024","author":"C Geng","year":"2024","unstructured":"Geng C, Liang B, Kong Z, et al. Metabolomic profiling reveals biomarkers in coronary heart disease comorbidity[J]. J Diabetes Res. 2024;2024(1):8559677.","journal-title":"J Diabetes Res"},{"issue":"3","key":"2820_CR79","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.numecd.2023.10.029","volume":"34","author":"\u00c5M Moe","year":"2024","unstructured":"Moe \u00c5M, Ytterstad E, Hopstock LA, et al. Associations and predictive power of dietary patterns on metabolic syndrome and its components[J]. Nutr Metabol Cardiovasc Dis. 2024;34(3):681\u201390.","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"7640","key":"2820_CR80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"8","key":"2820_CR81","first-page":"1213","volume":"65","author":"B Lau","year":"2022","unstructured":"Lau B, et al. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective. Diabetologia. 2022;65(8):1213\u201328.","journal-title":"Diabetologia"},{"issue":"4","key":"2820_CR82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance: an epidemiological analysis. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2820_CR83","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","volume":"122","author":"AR Tall","year":"2018","unstructured":"Tall AR, Rader DJ. The trials and tribulations of CETP inhibitors. Circ Res. 2018;122(1):106\u201312.","journal-title":"Circ Res"},{"issue":"1","key":"2820_CR84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12872-023-03145-7","volume":"23","author":"L Yin","year":"2023","unstructured":"Yin L, et al. Associations of cardiometabolic index, lipid accumulation product and visceral adiposity index with cardiometabolic Multimorbidity in hypertensive patients. BMC Cardiovasc Disord. 2023;23(1):189.","journal-title":"BMC Cardiovasc Disord"},{"key":"2820_CR85","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436\u201344.","journal-title":"Nature"},{"key":"2820_CR86","doi-asserted-by":"crossref","unstructured":"Dietterich TG. Ensemble methods in machine learning. Multiple Classifier Syst 2000:1\u201315.","DOI":"10.1007\/3-540-45014-9_1"},{"key":"2820_CR87","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30:4765\u201374.","journal-title":"Adv Neural Inf Process Syst"},{"issue":"23","key":"2820_CR88","first-page":"e018876","volume":"9","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan W, Chen R. Machine learning-based stroke risk prediction in an elderly UK cohort: incorporating composite metabolic indices. J Am Heart Association. 2020;9(23):e018876.","journal-title":"J Am Heart Association"},{"issue":"12","key":"2820_CR89","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","volume":"4","author":"AD Sniderman","year":"2019","unstructured":"Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano AL. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4(12):1287\u201395.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"2820_CR90","first-page":"385","volume":"30","author":"A Varbo","year":"2019","unstructured":"Varbo A, Nordestgaard BG. Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease. Curr Opin Lipidol. 2019;30(5):385\u201391.","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"2820_CR91","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2820_CR92","first-page":"1","volume":"7","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance: an update. Lipids Health Dis. 2008;7(1):1\u20136.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2820_CR93","first-page":"699","volume":"85","author":"SH Lee","year":"2016","unstructured":"Lee SH, Han K, Yang HS, Kim HB, Cho JH, Kwon H-S, et al. Identifying subgroups of obesity using the product of triglycerides and glucose: the Korea National health and nutrition examination Survey, 2008\u20132010. Clin Endocrinol (Oxf). 2016;85(5):699\u2013706.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2820_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang D, Yang H, Chen S, Xu W, Wang F. Triglyceride-glucose index and the risk of cardiovascular events in patients with coronary artery disease: a prospective cohort study. Cardiovasc Diabetol. 2020;19(1):1\u201310.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2820_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5(1):1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"2820_CR96","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917\u201323.","journal-title":"Hepatology"},{"issue":"10","key":"2820_CR97","first-page":"1002","volume":"24","author":"P L\u00f3pez-Jaramillo","year":"2014","unstructured":"L\u00f3pez-Jaramillo P, Lahera V, L\u00f3pez-Lopez J, Rodr\u00edguez-Salda\u00f1a J, Camacho PA, Cohen DD. The lipid accumulation product and obesity phenotypes: relationship with insulin resistance in adults with normal weight, overweight and obesity. Nutr Metab Cardiovasc Dis. 2014;24(10):1002\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"2820_CR98","first-page":"210","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen L, Zhao M. Cold exposure and cardiometabolic health: evidence from Northern China. J Cardiovasc Metabolism. 2023;15(4):210\u20139.","journal-title":"J Cardiovasc Metabolism"},{"issue":"1","key":"2820_CR99","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-022-01565-x","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Sun H, Wang R. Regional disparities in cardiometabolic disease burden in China: a nationwide epidemiological analysis. Cardiovasc Diabetol. 2022;21(1):134\u201345.","journal-title":"Cardiovasc Diabetol"},{"key":"2820_CR100","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.lanwpc.2021.100178","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Li Q, Zhang H. Quantifying the contribution of dietary and environmental factors to north-south cardiovascular mortality differences in China. Lancet Reg Health - Western Pac. 2021;12:100178\u201386.","journal-title":"Lancet Reg Health - Western Pac"},{"issue":"2","key":"2820_CR101","doi-asserted-by":"crossref","first-page":"27001","DOI":"10.1289\/EHP11248","volume":"131","author":"M Li","year":"2023","unstructured":"Li M, Zhou X, Hu B. Air pollution, metabolic disorders, and cardiovascular risk: A population-based study in Northern China. Environ Health Perspect. 2023;131(2):27001\u201310.","journal-title":"Environ Health Perspect"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02820-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:03:26Z","timestamp":1769072606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-025-02820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2820"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02820-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Peking University and conducted in accordance with the Declaration of Helsinki. Ethical approval for household questionnaires and physical measurements was granted under IRB00001052-11015, and for biomarker collection under IRB00001052-11014. All procedures were performed in accordance with local legislation and institutional requirements. Written informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"22"}}